Anaphylaxis caused by muscle relaxant (eperisone hydrochloride)

Sung Hyun Kim; Jaechun Lee; Su Hee Kim; Hyun Woo Kim; Young Uck Kim; Younghyup Lim; Shinhang Moon; Jaecheol Moon; Dahee Heo

doi:10.4168/aard.2013.1.2.172

Journal List > Allergy Asthma Respir Dis > v.1(2) > 1058953

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Kim, Lee, Kim, Kim, Kim, Lim, Moon, Moon, and Heo: Anaphylaxis caused by muscle relaxant (eperisone hydrochloride)

Case Report

Allergy, Asthma & Respiratory Disease 2013; 1(2): 172-175.

Published online: 27 June 2013

DOI: https://doi.org/10.4168/aard.2013.1.2.172

Anaphylaxis caused by muscle relaxant (eperisone hydrochloride)

Sung Hyun Kim, Jaechun Lee, Su Hee Kim, Hyun Woo Kim, Young Uck Kim, Younghyup Lim, Shinhang Moon, Jaecheol Moon, Dahee Heo

Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea.

Correspondence to: Jaechun Lee. Department of Internal Medicine, Jeju National University School of Medicine, 102 Jejudaehak-ro, Jeju 690-756, Korea. Tel: +82-64-754-3915, Fax: +82-64-725-2593, doc4u@hanmail.net

Received 20 March 2013 Revised 12 April 2013 Accepted 12 April 2013

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).

Abstract

Eperisone hydrochloride is an antispasmodic drug, decreasing spasticity of skeletal muscle and alleviating stiffness, and as a consequence, controlling pain. It is preferably prescribed with other analgesics, beneficially less decreasing alertness compared with other antispasmodics. Its fatal drug adverse reactions were rarely reported. A 70 year-old female with hives, swollen face, hoarse voice, and near fainting admitted via emergency department. She suffered from the series of the fatal symptoms after administration of the pills, prescribed for her neck pain. Two months before, she had experienced hives on similar medications. At presentation, she revealed hypoxemia and hypotension, and treated with epinephrine, glucocorticoids and antihistamines. Among the medicines she took, eperisone hydrochloride was proven as the causative medicine and others were excluded in oral provocation tests. The positive result in intradermal test with eperisone hydrochloride suggested immediate-type hypersensitivity reaction. We report a case of anaphylaxis to eperisone hydrochloride, one of the widely prescribed medicines in clinical practice, previously without awareness of drug adverse reaction.

Keywords: Anaphylaxis, Eperisone, Muscle relaxants, Immediate hypersensitivity, Drug hypersensitivity

Figures and Tables

Fig. 1

Generalized hives with periorbital and neck angioedema developed in 30 minutes after oral administration of eperisone hydrochloride 25 mg in oral provocation test.

Fig. 2

Intradermal tests with eperisone hydrochloride and saline as a negative control. 11 mm×9 mm sized wheal reaction was observed at intradermal injection of eperisone hydrochloride (E). No wheal was seen in saline (-).

References

1. Inoue S, Bian K, Okamura T, Okunishi H, Toda N. Mechanisms of action of eperisone on isolated dog saphenous arteries and veins. Jpn J Pharmacol. 1989; 50:271–282.

2. Iwase S, Mano T, Saito M, Ishida G. Effect of a centrally-acting muscle relaxant, eperisone hydrochloride, on muscle sympathetic nerve activity in humans. Funct Neurol. 1992; 7:459–470.

3. Matsunaga M, Uemura Y, Yonemoto Y, Kanai K, Etoh H, Tanaka S, et al. Long-lasting muscle relaxant activity of eperisone hydrochloride after percutaneous administration in rats. Jpn J Pharmacol. 1997; 73:215–220.

4. Ochiai T, Ishida R. Pharmacological studies on 6-amino-2-fluoromethyl-3-(O-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. (II) Effects on the spinal reflex potential and the rigidity. Jpn J Pharmacol. 1982; 32:427–438.

5. Kim YK. Drug allergy update. J Asthma Allergy Clin Immunol. 2000; 20:855–865.

6. Lee AY. Drug allergy update. J Asthma Allergy Clin Immunol. 2002; 22:669–676.

7. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy. 2002; 57:45–51.

8. Suzuki Y, Ra C. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: aspirin modulation of IgE-dependent mast cell activation: role of aspirin-induced exacerbation of immediate allergy. J Pharmacol Sci. 2009; 110:237–244.

9. Choonhakarn C. Non-pigmenting fixed drug eruption: a new case due to eperisone hydrochloride. Br J Dermatol. 2001; 144:1288–1289.

10. Ueno T, Kawana S. A case of eperisone hydrochloride (myonal): induced drug eruption leading to erythema and angioedema. Arerugi. 2007; 56:709–713.

11. Demitsu T, Tomita Y. Fixed drug eruption due to afloqualone: the first reported case. J Dermatol. 1998; 25:136.

12. Ribi C, Vermeulen C, Hauser C. Anaphylactic reactions to tolperisone (Mydocalm). Swiss Med Wkly. 2003; 133:369–371.

13. Hur GY, Hwang EK, Moon JY, Ye YM, Shim JJ, Park HS, et al. Oral muscle relaxant may induce immediate allergic reactions. Yonsei Med J. 2012; 53:863–865.

14. Cho YJ. Update on the diagnosis of drug allergy. Korean J Med. 2009; 76:282–290.

15. Reshef A, Kagey-Sobotka A, Adkinson NF Jr, Lichtenstein LM, Norman PS. The pattern and kinetics in human skin of erythema and mediators during the acute and late-phase response (LPR). J Allergy Clin Immunol. 1989; 84(5 Pt 1):678–687.

16. Makabe-Kobayashi Y, Hori Y, Adachi T, Ishigaki-Suzuki S, Kikuchi Y, Kagaya Y, et al. The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxis. J Allergy Clin Immunol. 2002; 110:298–303.

TOOLS

Similar articles